GSA Capital Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
IA
BTI
CFB
HNB
GSA Capital Partners's SYNH Position: Q3 2023 in Review
GSA Capital Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 7,642 shares — an estimated $322K sold.
GSA Capital Partners first reported a position in SYNH in Q1 2015 and held it in 19 quarters. The position peaked at $4.59M in Q3 2016. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- GSA Capital Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- GSA Capital Partners sold 7,642 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $322K.
- GSA Capital Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 19 quarters.
- GSA Capital Partners's Syneos Health, Inc. Class A Common Stock position peaked at $4.59M in Q3 2016.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.